Review



aav serotype 8 shrna targeting sptlc2  (Vector Biolabs)


Bioz Verified Symbol Vector Biolabs is a verified supplier
Bioz Manufacturer Symbol Vector Biolabs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Vector Biolabs aav serotype 8 shrna targeting sptlc2
    Myriocin (MYR) treatment reduced chronic dexamethasone exposure–induced hepatic steatosis and hypertriglyceridemia. WT and Angptl4−/− mice were treated with dexamethasone (0.84 mg/kg body weight) in drinking water for 7 days. Half of the mice received daily intraperitoneal injections of myriocin (0.5 mg/kg body weight) on days 4–7. A and B, at the end of treatment, the levels of TG in plasma (A) and liver (B) were measured. The error bars represent standard deviation (n = 6–8). *, p < 0.5. C, RNA from the liver of these mice was isolated, and the expression of genes involved in TG homeostasis was monitored by real-time PCR. The error bars represent S.E. (n = 7–9). *, p < 0.05. D, liver and epididymal white adipose tissue RNA was isolated, and gene expression for Angptl4 was measured. The error bars represent S.E. (n = 7–9). *, p < 0.05. WT mice were infected with adeno-associated virus (AAV8) expressing shRNA for scramble or <t>Sptlc2</t> and were treated with dexamethasone for 2 weeks. E, liver was harvested and analyzed for decreased expression of Sptlc2. F and G, plasma (F) and liver (G) triglyceride levels were measured. The error bars represent standard deviation (n = 3–4). *, p < 0.05.
    Aav Serotype 8 Shrna Targeting Sptlc2, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav serotype 8 shrna targeting sptlc2/product/Vector Biolabs
    Average 90 stars, based on 3 article reviews
    aav serotype 8 shrna targeting sptlc2 - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "An ANGPTL4–ceramide–protein kinase Cζ axis mediates chronic glucocorticoid exposure–induced hepatic steatosis and hypertriglyceridemia in mice"

    Article Title: An ANGPTL4–ceramide–protein kinase Cζ axis mediates chronic glucocorticoid exposure–induced hepatic steatosis and hypertriglyceridemia in mice

    Journal: The Journal of Biological Chemistry

    doi: 10.1074/jbc.RA118.006259

    Myriocin (MYR) treatment reduced chronic dexamethasone exposure–induced hepatic steatosis and hypertriglyceridemia. WT and Angptl4−/− mice were treated with dexamethasone (0.84 mg/kg body weight) in drinking water for 7 days. Half of the mice received daily intraperitoneal injections of myriocin (0.5 mg/kg body weight) on days 4–7. A and B, at the end of treatment, the levels of TG in plasma (A) and liver (B) were measured. The error bars represent standard deviation (n = 6–8). *, p < 0.5. C, RNA from the liver of these mice was isolated, and the expression of genes involved in TG homeostasis was monitored by real-time PCR. The error bars represent S.E. (n = 7–9). *, p < 0.05. D, liver and epididymal white adipose tissue RNA was isolated, and gene expression for Angptl4 was measured. The error bars represent S.E. (n = 7–9). *, p < 0.05. WT mice were infected with adeno-associated virus (AAV8) expressing shRNA for scramble or Sptlc2 and were treated with dexamethasone for 2 weeks. E, liver was harvested and analyzed for decreased expression of Sptlc2. F and G, plasma (F) and liver (G) triglyceride levels were measured. The error bars represent standard deviation (n = 3–4). *, p < 0.05.
    Figure Legend Snippet: Myriocin (MYR) treatment reduced chronic dexamethasone exposure–induced hepatic steatosis and hypertriglyceridemia. WT and Angptl4−/− mice were treated with dexamethasone (0.84 mg/kg body weight) in drinking water for 7 days. Half of the mice received daily intraperitoneal injections of myriocin (0.5 mg/kg body weight) on days 4–7. A and B, at the end of treatment, the levels of TG in plasma (A) and liver (B) were measured. The error bars represent standard deviation (n = 6–8). *, p < 0.5. C, RNA from the liver of these mice was isolated, and the expression of genes involved in TG homeostasis was monitored by real-time PCR. The error bars represent S.E. (n = 7–9). *, p < 0.05. D, liver and epididymal white adipose tissue RNA was isolated, and gene expression for Angptl4 was measured. The error bars represent S.E. (n = 7–9). *, p < 0.05. WT mice were infected with adeno-associated virus (AAV8) expressing shRNA for scramble or Sptlc2 and were treated with dexamethasone for 2 weeks. E, liver was harvested and analyzed for decreased expression of Sptlc2. F and G, plasma (F) and liver (G) triglyceride levels were measured. The error bars represent standard deviation (n = 3–4). *, p < 0.05.

    Techniques Used: Clinical Proteomics, Standard Deviation, Isolation, Expressing, Real-time Polymerase Chain Reaction, Gene Expression, Infection, Virus, shRNA



    Similar Products

    aav serotype 8 shrna targeting sptlc2  (Vector Biolabs)
    90
    Vector Biolabs aav serotype 8 shrna targeting sptlc2
    Myriocin (MYR) treatment reduced chronic dexamethasone exposure–induced hepatic steatosis and hypertriglyceridemia. WT and Angptl4−/− mice were treated with dexamethasone (0.84 mg/kg body weight) in drinking water for 7 days. Half of the mice received daily intraperitoneal injections of myriocin (0.5 mg/kg body weight) on days 4–7. A and B, at the end of treatment, the levels of TG in plasma (A) and liver (B) were measured. The error bars represent standard deviation (n = 6–8). *, p < 0.5. C, RNA from the liver of these mice was isolated, and the expression of genes involved in TG homeostasis was monitored by real-time PCR. The error bars represent S.E. (n = 7–9). *, p < 0.05. D, liver and epididymal white adipose tissue RNA was isolated, and gene expression for Angptl4 was measured. The error bars represent S.E. (n = 7–9). *, p < 0.05. WT mice were infected with adeno-associated virus (AAV8) expressing shRNA for scramble or <t>Sptlc2</t> and were treated with dexamethasone for 2 weeks. E, liver was harvested and analyzed for decreased expression of Sptlc2. F and G, plasma (F) and liver (G) triglyceride levels were measured. The error bars represent standard deviation (n = 3–4). *, p < 0.05.
    Aav Serotype 8 Shrna Targeting Sptlc2, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/aav serotype 8 shrna targeting sptlc2/product/Vector Biolabs
    Average 90 stars, based on 1 article reviews
    aav serotype 8 shrna targeting sptlc2 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    virus aav serotype 8 shrna targeting sptlc2  (Vector Biolabs)
    90
    Vector Biolabs virus aav serotype 8 shrna targeting sptlc2
    Myriocin (MYR) treatment reduced chronic dexamethasone exposure–induced hepatic steatosis and hypertriglyceridemia. WT and Angptl4−/− mice were treated with dexamethasone (0.84 mg/kg body weight) in drinking water for 7 days. Half of the mice received daily intraperitoneal injections of myriocin (0.5 mg/kg body weight) on days 4–7. A and B, at the end of treatment, the levels of TG in plasma (A) and liver (B) were measured. The error bars represent standard deviation (n = 6–8). *, p < 0.5. C, RNA from the liver of these mice was isolated, and the expression of genes involved in TG homeostasis was monitored by real-time PCR. The error bars represent S.E. (n = 7–9). *, p < 0.05. D, liver and epididymal white adipose tissue RNA was isolated, and gene expression for Angptl4 was measured. The error bars represent S.E. (n = 7–9). *, p < 0.05. WT mice were infected with adeno-associated virus (AAV8) expressing shRNA for scramble or <t>Sptlc2</t> and were treated with dexamethasone for 2 weeks. E, liver was harvested and analyzed for decreased expression of Sptlc2. F and G, plasma (F) and liver (G) triglyceride levels were measured. The error bars represent standard deviation (n = 3–4). *, p < 0.05.
    Virus Aav Serotype 8 Shrna Targeting Sptlc2, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/virus aav serotype 8 shrna targeting sptlc2/product/Vector Biolabs
    Average 90 stars, based on 1 article reviews
    virus aav serotype 8 shrna targeting sptlc2 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Myriocin (MYR) treatment reduced chronic dexamethasone exposure–induced hepatic steatosis and hypertriglyceridemia. WT and Angptl4−/− mice were treated with dexamethasone (0.84 mg/kg body weight) in drinking water for 7 days. Half of the mice received daily intraperitoneal injections of myriocin (0.5 mg/kg body weight) on days 4–7. A and B, at the end of treatment, the levels of TG in plasma (A) and liver (B) were measured. The error bars represent standard deviation (n = 6–8). *, p < 0.5. C, RNA from the liver of these mice was isolated, and the expression of genes involved in TG homeostasis was monitored by real-time PCR. The error bars represent S.E. (n = 7–9). *, p < 0.05. D, liver and epididymal white adipose tissue RNA was isolated, and gene expression for Angptl4 was measured. The error bars represent S.E. (n = 7–9). *, p < 0.05. WT mice were infected with adeno-associated virus (AAV8) expressing shRNA for scramble or Sptlc2 and were treated with dexamethasone for 2 weeks. E, liver was harvested and analyzed for decreased expression of Sptlc2. F and G, plasma (F) and liver (G) triglyceride levels were measured. The error bars represent standard deviation (n = 3–4). *, p < 0.05.

    Journal: The Journal of Biological Chemistry

    Article Title: An ANGPTL4–ceramide–protein kinase Cζ axis mediates chronic glucocorticoid exposure–induced hepatic steatosis and hypertriglyceridemia in mice

    doi: 10.1074/jbc.RA118.006259

    Figure Lengend Snippet: Myriocin (MYR) treatment reduced chronic dexamethasone exposure–induced hepatic steatosis and hypertriglyceridemia. WT and Angptl4−/− mice were treated with dexamethasone (0.84 mg/kg body weight) in drinking water for 7 days. Half of the mice received daily intraperitoneal injections of myriocin (0.5 mg/kg body weight) on days 4–7. A and B, at the end of treatment, the levels of TG in plasma (A) and liver (B) were measured. The error bars represent standard deviation (n = 6–8). *, p < 0.5. C, RNA from the liver of these mice was isolated, and the expression of genes involved in TG homeostasis was monitored by real-time PCR. The error bars represent S.E. (n = 7–9). *, p < 0.05. D, liver and epididymal white adipose tissue RNA was isolated, and gene expression for Angptl4 was measured. The error bars represent S.E. (n = 7–9). *, p < 0.05. WT mice were infected with adeno-associated virus (AAV8) expressing shRNA for scramble or Sptlc2 and were treated with dexamethasone for 2 weeks. E, liver was harvested and analyzed for decreased expression of Sptlc2. F and G, plasma (F) and liver (G) triglyceride levels were measured. The error bars represent standard deviation (n = 3–4). *, p < 0.05.

    Article Snippet: AAV serotype 8 shRNA targeting Sptlc2 was purchased from Vector Biolabs.

    Techniques: Clinical Proteomics, Standard Deviation, Isolation, Expressing, Real-time Polymerase Chain Reaction, Gene Expression, Infection, Virus, shRNA